Published in Allerg Immunol (Paris) on June 01, 1989
Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis. Immunology (1992) 0.80
Staphylococcus aureus modifies the cytokine-induced immunoglobulin synthesis and CD23 expression in patients with atopic dermatitis. Immunology (1991) 0.78
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol (1991) 1.98
Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors. Clin Exp Allergy (1996) 1.50
Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol (1992) 1.47
IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol (1992) 1.47
Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol (1996) 1.40
Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol (1991) 1.30
Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties. Protein Eng Des Sel (2010) 1.27
An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. J Leukoc Biol (1988) 1.23
Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol (1994) 1.20
Pharmacological effects of oximes: how relevant are they? Arch Toxicol (1996) 1.15
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood (1991) 1.11
IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost (2009) 1.08
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood (1992) 1.07
Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol (1993) 1.06
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol (1989) 1.04
IL-4-induced migration of eosinophils in allergic inflammation. Ann N Y Acad Sci (1994) 1.02
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen. Clin Exp Immunol (1989) 1.00
Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol (1988) 1.00
Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol (1992) 1.00
In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood (1992) 0.98
Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med (1993) 0.97
Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res (1997) 0.95
Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol (1996) 0.91
Antigen focusing by specific monomeric immunoglobulin E bound to CD23 on Epstein-Barr virus-transformed B cells. Hum Immunol (1993) 0.89
Human platelets secrete chemotactic activity for eosinophils. Blood (1993) 0.88
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion (1989) 0.88
Maternal antigen stimulation downregulates via mother's milk the specific immune responses in young mice. Int Arch Allergy Immunol (2001) 0.88
Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J Invest Dermatol (1995) 0.87
Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells. Int Arch Allergy Appl Immunol (1973) 0.86
Human tonsil B lymphocyte function. I. The proliferative response to Staphylococcus aureus and pokeweed mitogen in relation to surface heavy chains mu and delta. Clin Exp Immunol (1984) 0.86
Regulation of Fc epsilonRI expression on human monocytic cells by ligand and IL-4. Clin Exp Allergy (2000) 0.85
Induction of IgM production by pokeweed mitogen and interleukin-2: different responses by human peripheral blood cells and tonsil cells. Clin Immunol Immunopathol (1986) 0.85
Long-lived Th2 clones specific for seasonal and perennial allergens can be detected in blood and skin by their TCR-hypervariable regions. J Immunol (1998) 0.84
An automated method for registering and quantifying scratching activity in mice: use for drug evaluation. J Pharmacol Toxicol Methods (2001) 0.84
Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol (1998) 0.83
The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation. Transplantation (1989) 0.83
Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma. Immunobiology (1993) 0.83
Dermal absorption of polycyclic aromatic hydrocarbons in the blood-perfused pig ear. J Appl Toxicol (1995) 0.83
Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol (1993) 0.82
The eosinophilic granulocyte an active participant in the late phase asthmatic reaction? Bull Eur Physiopathol Respir (1986) 0.82
IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. J Invest Dermatol (1994) 0.81
Regulation and targeting of T-cell immune responses by IgE and IgG antibodies. Immunology (1995) 0.80
The Langerhans cell: an underestimated cell in atopic disease. Clin Exp Allergy (1990) 0.80
Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Exp Dermatol (2000) 0.80
Modulation of Fc gamma receptor-mediated early events by the tyrosine phosphatase CD45 in primary human monocytes. Consequences for interleukin-6 production. Eur J Immunol (1995) 0.80
Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. J Appl Toxicol (2001) 0.79
Human tonsil B lymphocyte function. II. Pokeweed mitogen-induced plasma cell differentiation of B cell subpopulations expressing multiple heavy chain isotypes on their surface. J Immunol (1984) 0.79
IgE production after antigen-specific and cognate activation of HLA-DPw4-restricted T-cell clones, by 78% of randomly selected B-cell donors. Hum Immunol (2000) 0.79
Behavioral test systems in marmoset monkeys. Behav Res Methods Instrum Comput (2000) 0.79
Mast cell heterogeneity in human lung tissue. Clin Sci (Lond) (1989) 0.79
IgE and atopic dermatitis. Clin Exp Allergy (1991) 0.79
Desensitization of the beta-adrenergic receptor on leucocytes after long-term oral use of a beta-sympathicomimetic; its effect on the beta-adrenergic blockade hypothesis of Szentivanyi. Ann Allergy (1979) 0.79
Efficacy of Curosurf in a rat model of acute respiratory distress syndrome. Eur Respir J (1998) 0.79
Blood lymphocyte subpopulations in extrinsic and intrinsic asthmatics. Ann Allergy (1987) 0.79
T cells and asthma. II. Regulation of the eosinophilia of asthma by T cell cytokines. Int Arch Allergy Appl Immunol (1991) 0.78
Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation. Clin Exp Immunol (1986) 0.78
Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils. J Immunol (1997) 0.78
Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. Pharmacol Biochem Behav (1998) 0.77
Role of Langerhans cells in atopic disease. Int Arch Allergy Appl Immunol (1989) 0.77
Evaluation of variables influencing the outcome of the atopy patch test. J Allergy Clin Immunol (1995) 0.77
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has opposing effects on the capacity of monocytes versus monocyte-derived dendritic cells to stimulate the antigen-specific proliferation of a human T cell clone. Clin Exp Immunol (2000) 0.77
MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation. J Invest Dermatol (1998) 0.77
Qualification and application of a surface plasmon resonance-based assay for monitoring potential HAHA responses induced after passive administration of a humanized anti Lewis-Y antibody. J Pharm Biomed Anal (2006) 0.77
Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions. J Allergy Clin Immunol (2000) 0.77
Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol (1996) 0.77
Leukotriene C4 formation by enriched human basophil preparations from normal and asthmatic subjects. Prostaglandins Leukot Essent Fatty Acids (1991) 0.77
Increased sensitivity of the chemoattractant-induced chemiluminescence in eosinophils isolated from atopic individuals. Immunology (1989) 0.77
New aspects in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) (1989) 0.77
Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav (2000) 0.77
Retention of long-lived, allergen-specific T cells in atopic dermatitis skin -letter-. J Invest Dermatol (1997) 0.76
An immunochemical assay to detect DNA damage in bovine sperm. J Androl (2000) 0.76
Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation. Bone Marrow Transplant (1987) 0.76
Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium. J Allergy Clin Immunol (1993) 0.75
Different growth factor requirements for human Th2 cells may reflect in vivo induced anergy. Clin Exp Immunol (1994) 0.75
Characteristics of Fc epsilon RI expression on human monocytes and monocytic cell lines: establishment of an in vitro model. Int Arch Allergy Immunol (1997) 0.75
T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma. Int Arch Allergy Appl Immunol (1991) 0.75
In vitro IgE but not IgG production of canine peripheral blood B cells is inhibited by CD40 ligation. Vet Immunol Immunopathol (2000) 0.75
Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol Sci (2000) 0.75
Regulation of FcARI expression on monocytic cell lines. Int Arch Allergy Immunol (1999) 0.75
Nedocromil sodium inhibits the early and late asthmatic response to exercise. Eur Respir J (1992) 0.75
New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol (1998) 0.75
The rate of percutaneous permeation of xylene, measured using the "perfused pig ear" model, is dependent on the effective protein concentration in the perfusing medium. Toxicol Appl Pharmacol (1994) 0.75
A novel regulatory mechanism for FcARI expression on human primary monocytes. Int Arch Allergy Immunol (1999) 0.75
The 'monocytic' cell line I937 displays typical B cell characteristics. Immunol Lett (1996) 0.75
Induction of cognate and non-cognate T-cell help for B-cell IgE production in relation to CD40 ligand expression. Int Arch Allergy Immunol (1996) 0.75
Peptide arrays for the determination of humoral responses induced by active immunization with a monoclonal antibody against EpCAM. J Immunol Methods (2006) 0.75
Mast cell subtypes from human lung tissue: their identification, separation, and functional characteristics. Agents Actions (1988) 0.75
Characterization of Fc epsilonRI expressing human monocytic cell lines. 1. The role of CD45 on signal transduction in primary monocytes and cell lines. Int Arch Allergy Immunol (1997) 0.75
The isolation of human lung mast cells by affinity chromatography. Scand J Immunol (1988) 0.75
Transplantation of marrow from donors other than genotypically HLA-identical siblings. Neth J Med (1987) 0.75
Non-reactivating effects of HI-6 on hippocampal neurotransmission. Arch Toxicol (1994) 0.75
[When is desensitization with bee and wasp venoms indicated in children?]. Ned Tijdschr Geneeskd (1984) 0.75